Drug · DIN 02565099
FIBRYGA
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since January 27, 2026.
- Drug Identification Number (DIN)
- 02565099
- Company (DIN owner)
- Octapharma Pharmazeutika Produktionsges M B HVienna, Vienne, Austria
- Schedule
- Schedule D
- Dosage form
- Powder For Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Fibrinogen, human B02BB01
- Class
- Human
- Record last updated
- February 23, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| FIBRINOGEN (HUMAN) | 2 G | VIAL |
Other DINs named FIBRYGA
- DIN 02464616 · Marketed